OTCMKTS:EQURE-QURE Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding E-QURE Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.08 0.00 (0.00 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$0.08Now: $0.08▼$0.0850-Day Range$0.06MA: $0.09▼$0.1152-Week Range$0.03Now: $0.08▼$0.16Volume20 shsAverage Volume40 shsMarket Capitalization$2.59 millionP/E RatioN/ADividend YieldN/ABeta3.22 ProfileAdvanced ChartCompetitorsEarningsHeadlinesSocial Media E-Qure Corp. focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. E-Qure Corp. is based in New York, New York.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for E-QURE. Previous Next 2.6 Community Rank Outperform VotesE-QURE has received 50 “outperform” votes. (Add your “outperform” vote.)Underperform VotesE-QURE has received 45 “underperform” votes. (Add your “underperform” vote.)Community SentimentE-QURE has received 52.63% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about E-QURE and other stocks. Vote “Outperform” if you believe EQUR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EQUR will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldE-QURE does not currently pay a dividend.Dividend GrowthE-QURE does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, E-QURE insiders have not sold or bought any company stock.Percentage Held by Insiders79.63% of the stock of E-QURE is held by insiders. A high percentage of insider ownership can be a sign of company health. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.72 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Miscellaneous durable goods Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:EQUR Previous Symbol CUSIPN/A CIKN/A Webwww.e-qure.com Phone972-5442-7777Debt Debt-to-Equity RatioN/A Current Ratio0.58 Quick Ratio0.58Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-7.50Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on Equity-3.29% Return on Assets7.69%Miscellaneous Employees1 Outstanding Shares34,550,000Market Cap$2.59 million Next Earnings Date9/24/2020 (Estimated) OptionableNot Optionable OTC:EQUR Rates by TradingView Receive EQUR News and Ratings via Email Sign-up to receive the latest news and ratings for EQUR and its competitors with MarketBeat's FREE daily newsletter. E-QURE (OTCMKTS:EQUR) Frequently Asked Questions How has E-QURE's stock been impacted by COVID-19 (Coronavirus)? E-QURE's stock was trading at $0.08 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EQUR stock has decreased by 6.3% and is now trading at $0.0750. View which stocks have been most impacted by Coronavirus. When is E-QURE's next earnings date? E-QURE is scheduled to release its next quarterly earnings announcement on Thursday, September 24th 2020. View our earnings forecast for E-QURE. Has E-QURE been receiving favorable news coverage? Headlines about EQUR stock have been trending very negative on Monday, InfoTrie reports. The research group scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. E-QURE earned a daily sentiment score of -3.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about E-QURE. Who are some of E-QURE's key competitors? Some companies that are related to E-QURE include Acerus Pharmaceuticals (TRLPF), AEterna Zentaris (AEZS), biOasis Technologies (BTI), Anatara Lifesciences (ANR), PotNetwork (POTN), CBA Florida (CBAI), Adalta (1AD), Xtant Medical (XTNT), ANCHIANO THERAP/S (ANCN), Hypertension Diagnostics (HDII), Ovoca Bio (OVB), PlusTherapeuticsInc . (PSTV), Grown Rogue International (GRUSF), GT Biopharma (GTBP) and Hancock Jaffe Laboratories (HJLI). View all competitors. What other stocks do shareholders of E-QURE own? Based on aggregate information from My MarketBeat watchlists, some companies that other E-QURE investors own include Hexo (HEXO), Bertrandt (BDT), Blue Dolphin Energy (BDCO), American Power Group (APGI), Advanced Oxygen Technologies (AOXY), Aeolus Pharmaceuticals (AOLS), Advanced Micro Devices (AMD), Akari Therapeutics (AKTX), Aceto (ACET) and Aurora Cannabis (ACB). Who are E-QURE's key executives? E-QURE's management team includes the following people: Mr. Ohad Goren, CEO & Director (Age 48)Mr. Gal Peleg, Chief Financial Officer (Age 41)Mr. Itsik Ben Yesha, CTO & Director (Age 66)Mr. Itai Weisberg, Chief Marketing Consultant What is E-QURE's stock symbol? E-QURE trades on the OTCMKTS under the ticker symbol "EQUR." How do I buy shares of E-QURE? Shares of EQUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is E-QURE's stock price today? One share of EQUR stock can currently be purchased for approximately $0.08. How big of a company is E-QURE? E-QURE has a market capitalization of $2.59 million. E-QURE employs 1 workers across the globe. What is E-QURE's official website? The official website for E-QURE is www.e-qure.com. How can I contact E-QURE? E-QURE's mailing address is 20 WEST 64TH STREET SUITE 39G, NEW YORK NY, 10023. The company can be reached via phone at 972-5442-7777. This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
